TECH vs TXT · P/E 65, rev $1.22B vs P/E 19, rev $13.70B
Bio-Techne Corp (TECH) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TXT revenue for 2024-12-28 was $13.70B. Net income was $824.0M. Revenue was up 0.1% from 2023-12-30 to 2024-12-28. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the TECH and TXT stock pages for the full models.
Not investment advice.